Hyaluronic Acid Filler - Spherical Technology

Buy Revanesse Wholesale NYC

Hyaluronic Acid (HA) | Spherical Particle Technology | Select Quantity Below

From $120.00 / syringe

4.9 / 5.0 - 318 reviews

Revanesse Versa+ - 1 Syringe (1mL)Single syringe - mid-face, nasolabial folds, lip volume

$120.00

Revanesse Versa+ - 2 Syringes (2mL)Dual syringe - comprehensive mid-face or multi-zone treatment

$158.00

Revanesse Versa+ - 5-Pack (5 - 1mL)Best value - full clinic stock pack

$210.00

Your Selection

Order Total$0.00

Spherical HA particle technology - natural volume, minimal swelling, exceptional patient satisfaction

Revanesse Versa+ is a next-generation HA filler manufactured by Prollenium Medical Technologies in Canada. Its unique spherical particle technology creates a more uniform gel matrix than conventional HA fillers - resulting in smoother integration, more natural-looking volume, and significantly less post-treatment edema compared to leading competitors in clinical studies.

Spherical HA particle technology - less post-treatment swelling than leading HA fillers in clinical trials
FDA-approved for correction of moderate to severe nasolabial folds
24mg/mL HA concentration with lidocaine - comfortable injection experience and long-lasting results

Delivery

Fast Tracked Priority

Sourcing

Authentic Products

Support

Friendly Customer Care

Back to Dermal Fillers

Revanesse Versa+ - Spherical HA Innovation

Revanesse Versa+ is manufactured by Prollenium Medical Technologies, a Canadian company specializing in premium HA filler development. The "Versa+" name reflects the product's versatility - a single formulation capable of treating multiple facial zones with consistent, natural-looking results.

The product's defining innovation is its spherical HA particle technology. Conventional HA fillers use irregular-shaped particles that can create localized micro-irregularities in the tissue. Revanesse Versa+ employs a manufacturing process that produces near-perfect spherical HA particles - creating a smoother, more homogenous gel that integrates uniformly with surrounding tissue. In a 2019 comparative clinical study, Versa+ demonstrated 24% less post-treatment edema (swelling) than a leading competitor at day 1.

Why Injectors Choose Revanesse Versa+

01Spherical particle technology - 24% less post-injection swelling vs. leading competitors (clinical study, 2019)
0224mg/mL HA with 0.3% lidocaine - comfortable injection and long-lasting correction
03FDA-approved for moderate to severe nasolabial folds - with strong off-label use data for lips and mid-face
04Versatile single-product solution - injectors use Versa+ across multiple facial zones with consistent results
05Reversible with hyaluronidase - complete safety profile consistent with premium HA fillers

Product Specifications

Manufacturer	Prollenium Medical Technologies, Ontario, Canada
Active Ingredient	Cross-linked Hyaluronic Acid (HA) 24mg/mL
Technology	Spherical HA Particle Technology
Lidocaine	0.3% lidocaine HCl
Volume	1mL per syringe
FDA Approval	Approved - nasolabial fold correction
Longevity	12 months (area dependent)
Price Range	$120.00 - $210.00

Versa+ vs. Conventional HA Fillers

Particle Shape - Spherical (Versa+) vs. irregular (conventional HA) - smoother tissue integration

Post-Treatment Edema - 24% less swelling at Day 1 vs. leading competitor (2019 clinical study)

Comfort - Contains 0.3% lidocaine for reduced injection discomfort

Reversibility - Fully reversible with hyaluronidase injection

How Revanesse Versa+ Works

Step 1 - Consultation & Mapping

The injector assesses facial anatomy, identifies treatment zones (nasolabial folds, lips, mid-face), and determines the volume of Versa+ required. A topical numbing agent may be applied to the skin surface prior to injection - though the 0.3% lidocaine in the formulation provides significant intra-procedural comfort.

Step 2 - Injection

Versa+ is injected into the mid-dermis or deep dermis depending on the treatment zone and depth of correction required. The spherical particle matrix integrates evenly with surrounding tissue, creating immediate volume and smooth surface correction without lumping or irregularity.

Step 3 - Immediate Results

Correction is visible immediately post-treatment. Due to the spherical particle technology, post-treatment swelling is significantly reduced compared to conventional HA fillers. Most patients can return to normal activities immediately, with any minor swelling or bruising typically resolving within 24-72 hours.

Step 4 - Longevity & Maintenance

Results typically last 12 months, with longevity depending on treatment area, volume injected, and individual patient metabolism. Follow-up treatments maintain correction over time. HA is gradually metabolized by the body - hyaluronidase can be used to dissolve the filler at any time if desired.

Ideal Candidates for Revanesse Versa+

Revanesse Versa+ is an excellent choice for patients who want effective volume correction with minimal downtime. Its low-swelling profile makes it particularly attractive for patients with busy lifestyles who cannot accommodate extended post-treatment recovery. The lidocaine formulation also makes it a good option for patients with injection anxiety.

Best Suited For

+Patients with moderate to severe nasolabial folds seeking natural-looking correction
+Lip augmentation patients who want volume with minimal post-treatment swelling
+Patients with active social or professional schedules requiring minimal downtime
+Injectors seeking a versatile, high-satisfaction single-product solution for multiple facial zones

Contraindications

-Known hypersensitivity to hyaluronic acid or lidocaine
-Active skin infection, inflammation, or herpes simplex at the treatment site
-Pregnancy or breastfeeding - safety not established
-Patients on anticoagulants - increased bruising risk at injection sites

See Important Safety Information below.

Revanesse Versa+ uses spherical HA particle technology, which produces a more uniform gel matrix. In a 2019 clinical study, Versa+ demonstrated 24% less post-treatment swelling at Day 1 compared to a leading competitor. This makes it ideal for patients wanting correction with minimal downtime.

Results typically last approximately 12 months, depending on treatment area, volume injected, and individual patient metabolism. High-movement areas like the lips may metabolize the filler more quickly than lower-movement areas like the nasolabial folds.

Yes. Revanesse Versa+ contains 0.3% lidocaine hydrochloride, which significantly improves injection comfort. Patients with known lidocaine hypersensitivity should not receive this product - consult the full prescribing information.

While FDA approval is specifically for nasolabial fold correction, Revanesse Versa+ is widely used off-label for lip augmentation by experienced injectors. Its spherical particle technology and lower-swelling profile make it particularly suitable for lip treatment. All off-label use should follow clinical best practices and informed consent protocols.